Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2009-08-25 Regulatory Filings
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings Classification · 95% confidence The document is a press release dated August 25, 2009, announcing that Wyeth will take over all R&D activities for a joint research project from Karo Bio, effective September 1, 2009. This is a specific corporate announcement regarding a change in a partnership agreement and the continuation of a research project, not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It details a strategic operational change. Since it is a specific announcement about corporate activity/strategy that doesn't fit perfectly into M&A (TAR) or Capital (CAP), it is best classified as a general Regulatory Filing (RNS) or potentially a general corporate update. Given the options, RNS serves as the best general regulatory/corporate announcement fallback for non-standard disclosures like this partnership update, although it is not a standard regulatory form filing. It is not a Call Transcript (CT), Director's Dealing (DIRS), or a formal Audit Report (AR). It is a specific corporate action announcement.
2009-08-25 Swedish
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for a specific instrument (Aktier SE0000571416) involving a holder (Nordnet AB (publ)) and an issuer (Karo Healthcare AB). It explicitly states the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, culminating in a new percentage of voting rights (4.97%). This structure perfectly matches the definition of a Major Shareholding Notification, which reports changes in significant ownership levels crossing thresholds.
2009-08-24 English
Regulatory Filings 2009
Regulatory Filings Classification · 85% confidence The document is a press release dated August 6, 2009, announcing that Karo Bio's ER-beta project was selected as one of the top ten attractive neuroscience partnership projects by Windhover Information Inc. It details the selection criteria, quotes management, and provides background information on ER-beta and Karo Bio. This type of announcement, focusing on business development, partnerships, and strategic positioning rather than routine financial results (like 10-K, ER, or IR) or management changes (MANG), fits best under a general business/corporate update. Since it is not a formal regulatory filing like a 10-K, nor a specific financial report, and it is not a proxy statement (DEF 14A) or a dividend notice (DIV), the most appropriate classification among the provided options for a significant corporate/business development announcement that isn't a standard financial report is often the general Regulatory Filings (RNS) category, as it is a public announcement of corporate news. However, given the focus on partnership potential and strategic positioning, it strongly resembles an Investor Presentation (IP) content, but it is structured as a press release, not a formal presentation deck. Since it is a press release announcing a business development milestone (selection for partnership presentation), and it doesn't fit perfectly into the other specific categories, RNS (Regulatory Filings/General Announcement) is the safest fallback, although it shares characteristics with Investor Presentation material. Given the context of a press release announcing selection for a partnership meeting, it is a general corporate announcement. I will classify it as RNS as the best fit for a non-standard, non-financial press release.
2009-08-06 Swedish
Earnings Release 2009
Earnings Release Classification · 95% confidence The document is a press release dated August 6, 2009, announcing that Karo Bio's ER-beta program was selected as one of the top 10 most interesting Neuroscience projects for partnering. It details recognition received from an analyst group (Windhover) and mentions an upcoming presentation at a partnering meeting. This type of announcement, focusing on business development, partnership potential, and recognition of a specific drug program, is characteristic of an Earnings Release (ER) or a general business update. Since it is an announcement of positive news regarding pipeline progress and partnership potential, and not a formal financial statement (like 10-K or IR) or a transcript (CT), the most fitting category is Earnings Release (ER), as these often contain business highlights alongside any financial results, or sometimes serve as the primary business update when formal quarterly reports are not due. Given the focus on program selection and partnering opportunities, it functions as a key business highlight announcement. FY 2009
2009-08-06 English
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim financial report (Delårsrapport) for the period January-June 2009. It contains detailed financial statements, management commentary, research and development updates, and financial tables. It is not a short announcement or a certification, but the full report itself, fitting the definition of an Interim/Quarterly Report. H1 2009
2009-07-14 Swedish
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY–JUNE 2009' and contains comprehensive financial statements, including net sales, operating expenses, profit/loss, and cash flow data for the specified period. It provides a detailed management discussion and analysis of business operations, R&D projects, and financial position. As it contains substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2009
2009-07-14 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.